Providing Market Intelligence for 40 Years

In The News

How mHealth developers can avoid ethical dilemmas

The ethical issues around mHealth are one reason consumers are wary of health devices, and many deal closely with the privacy of what is a person's most private information. A recent Parks Associates report found that about 35 percent of consumers say they fear their health data will not remain confidential if put online, and 23 percent of broadband household owners cite privacy and security concerns in using connected health devices.

The JMIR viewpoint's authors add that there currently is no regulation of mHealth devices or apps, and no guarantee that they provide clinically accurate information. However, this summer the U.S. Food and Drug Administration released guidelines for how it intends to regulate the marketing of mHealth apps that meet the definition of medical devices.

From the article "How mHealth developers can avoid ethical dilemmas" by Judy Mottl.

Previously In The News

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

AT&T gooses $45 prepaid plan with cheaper iPhones

And, as a recent report from Parks Associates noted, consumers are increasingly drawn to the simplified pricing offers in prepaid. The firm said that “currently postpaid carriers are starting to explo...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...